Sta znaci na Engleskom BIO JE ZNAČAJNO - prevod na Енглеском

• was significantly
• were significantly

Примери коришћења Bio je značajno на Хрватском и њихови преводи на Енглески

InductOs 1, 5 mg/ml bio je značajno djelotvoran(u usporedbi sa standardnom skrbi) u bolesnika s anamnezom pušenja ili bez nje.
InductOs 1.5 mg/ml was significantly effective(compared to standard care) in patients both with or without a history of smoking.

Medijan vremena do prvog pogoršanja, prema SZO ljestvici funkcionalnoga statusa, bio je značajno dulji u TPF skupini u odnosu na PF skupinu.
Median time to first deterioration of WHO performance status was significantly longer in the TPF arm compared to PF.

Proračunski manjak Grčke u 2010. godini bio je značajno veći no što je vlada procijenila, pokazuju podatci Eurostata objavljeni u utorak 26. travnja.
Greece's budget deficit in 2010 was significantly bigger than the government had estimated, Eurostat data revealed on Tuesday April 26th.

Broj bolesnika u kojih nije bilo novih erozija ili je promjena u odnosu na početno stanje ukupnog broja bodova na vdH-S ljestvici iznosila ≤ 0 bio je značajno veći u skupini liječenoj lijekom Simponi nego u kontrolnoj skupini p 0, 003.
The number of patients with no new erosions or a change from baseline in total vdH-S Score≤ 0 was significantly higher in the Simponi treatment group than in the control group p 0.003.

Veći dio zgrade bio je značajno oštećen tijekom gradskog požara 1923., ali je 1929. obnovljen prema nacrtima njemačkog arhitekta Martina Dülfera.
The building was extensively damaged by a fire in 1923 during an anniversary celebration, but was reconstructed in 1929 by German architect Martin Dülfer.

Nadalje, omjer težine organa u odnosu na terminalnu tjelesnu težinu bio je značajno povećan kod pasjemenika, repa pasjemenika, testisa i sjemenih vrećica.
In addition, the ratio of organ weight to terminal body weight was significantly increased for epididymis, cauda epididymis, testes and seminal vesicles.

Proces glasovanja bio je značajno unaprjeđen u usporedbi s parlamentarnim izborima 2008. godine", istaknuo je Jorgen Poulsen, član Parlamentarne skupštine Vijeće Europe u priopćenju za mediji koje je objavila misija OESS-a/ ODIHR-a.
The voting process was significantly improved from the parliamentary elections in 2008," said Jorgen Poulsen, member of the Parliamentary Assembly of the Council of Europe, as quoted in an OSCE/ODIHR press release.

Neuspjeh liječenja uzrokovan nedovoljnom djelotvornošću bio je značajno(p=0,0003) češći s atosibanom(n=48; 14,2%), nego u žena liječenih β-agonistom n=20; 5, 8.
Treatment failures caused by insufficient efficacy were significantly(p=0.0003) more frequent in atosiban(n=48, 14.2%) than in the β-agonist-treated women n=20, 5.8.

U oba ispitivanja INPULSIS, udio osoba s odgovorom u FVC-u, definiranih kao bolesnici s apsolutnim smanjenjem FVC-a izraženog kao%-tak previđene normalne vrijednosti, koje ne prelazi 5%(prag koji ukazuje na povećani rizik od smrtnosti u IPF-u), bio je značajno viši u skupini koja je primala nintedanib u usporedbi s placebom.
In both INPULSIS trials, the proportion of FVC responders, defined as patients with an absolute decline in FVC% predicted no greater than 5%(a threshold indicative of the increasing risk of mortality in IPF), was significantly higher in the nintedanib group as compared to placebo.

Broz razvedenih brakova roditelja učenika bio je značajno veći u skupini s psihosomatskim poremećajima(52,20%) nego u skupini zdravih učenika(15,10%).
The number of divorced parents was significantly higher in the group of students with psychosomatic disorders(52.20%) as compared with the group of healthy students(15.10%).

Zurampic blago smanjuje izloženost oksipurinolu(supstratu URAT1), glavnom metabolitu alopurinola; međutim, učinak na sniženje razine mokraćne kiseline bio je značajno veći za kombinaciju s alopurinolom nego za pojedinačne lijekove.
Zurampic slightly decreased exposure of oxypurinol(a URAT1 substrate), the major metabolite of allopurinol; however, the uric acid-lowering effect of the combination with allopurinol was significantly greater than for either substance alone.

Prvoga dana liječenja inspiratorni kapacitet pod naporom bio je značajno poboljšan(srednja vrijednost terapijske razlike dobivena metodom najmanjih kvadrata 250 ml, p<0,001) u usporedbi s placebom.
On the first day of treatment, inspiratory capacity under exercise was significantly improved(LS mean treatment difference 250 ml, p<0.001) compared to placebo.

Udio bolesnika liječenih tocilizumabom koji su nakon 12 tjedana pokazivali minimalno klinički značajno poboljšanje prema Upitniku za procjenu zdravlja djece- indeksu onesposobljenosti(definirano kao pojedinačno smanjenje ukupne ocjene ≥ 0,13) bio je značajno veći od udjela bolesnika koji su primali placebo, odnosno 77% naspram 19% p< 0, 0001.
At week 12, the proportion of tocilizumab treated patients showing a minimally clinically important improvement in the Childhood Health Assessment Questionnaire- Disability Index(defined as an individual total score decrease of≥ 0.13) was significantly higher than in placebo treated patients, 77% versus 19% p< 0.0001.

U sva tri ispitivanja prosječan dnevni prirast u završnom razdoblju bio je značajno veći u svinja cijepljenih VMP-om Porcilis PCV ID u usporedbi s necijepljenim svinjama.
In all three studies average daily weight gain in the finishing period was significantly higher in the pigs vaccinated with Porcilis PCV ID compared with the non-vaccinated pigs.

U ženki miševa, koje su primale intravenski alemtuzumab u dozama do 10 mg/kg na dan(AUC 4, 7 puta veći od izloženosti u ljudi pri preporučenoj dnevnoj dozi) tijekom 5 uzastopnih dana prije kohabitacije s mužjacima miševa divljeg tipa, prosječan broj žutih tijela i mjesta usadnje po ženki bio je značajno manji nego u životinja koje su primale vehikulum.
In female mice dosed with intravenous alemtuzumab up to 10 mg/kg/day(AUC of 4.7 times the human exposure at the recommended daily dose) for 5 consecutive days prior to cohabitation with wild-type male mice, the average number of corpora lutea and implantation sites per mouse were significantly reduced as compared to vehicle treated animals.

U tri kontrolirana klinička istraživanja nelagodan osjećaj u oku nakon ukapavanja AZARGE bio je značajno slabiji negoli pri primjeni dorzolamida 20 mg/ml+ timolola 5 mg/ml.
In three controlled clinical trials, the ocular discomfort upon instillation of AZARGA was significantly lower than that of dorzolamide 20 mg/ml+ timolol 5 mg/ml.

Srednji plućni krvožilni otpor bio je značajno manji u skupini koja je dobivala bosentan najveći učinak primijećen je u podskupini bolesnika koji su imali dvosmjerni unutarsrčani šant.
The mean pulmonary vascular resistance was significantly reduced in the bosentan group with a predominant effect observed in the subgroup of patients with bidirectional intracardiac shunt.

U oba pivotalna ispitivanja udio bolesnika u kojih se VMA povukla 28. dana(primarni ishod) bio je značajno veći(p≤0,003) u JETREA skupini u usporedbi s placebo skupinom.
In both pivotal studies, the proportion of patients who achieved VMA resolution at Day 28(primary endpoint) was significantly(p≤0.003) higher in the JETREA group compared with the placebo group.

Udio bolesnika kojima je sluznica zacijelila u 26. tjednu bio je značajno veći u skupini koja je primala infliksimab+ AZA(43,9%, p< 0,001) i skupini koja je primala monoterapiju infliksimabom(30,1%, p 0,023) nego u skupini koja je primala monoterapiju AZA 16, 5.
The proportions of patients with mucosal healing at week 26 were significantly greater in the infliximab plus AZA combination(43.9%, p< 0.001) and infliximab monotherapy groups(30.1%, p 0.023) compared to the AZA monotherapy group 16.5.

U glavnom ispitivanju koje je obuhvatilo 1 234 bolesnika, udio bolesnika koji su imali relaps tijekom razdoblja od dvije godine bio je značajno niži u slučaju liječenja lijekom Tecfidera nego placebom(prividnim liječenjem): 27% u odnosu na 46.
In a main study involving 1,234 patients, the proportion of patients who experienced a relapse over the course of two years was significantly lower with Tecfidera treatment than with placebo(a dummy treatment): 27% versus 46.

U ispitivanju INPULSIS-2 rizik od prve akutne egzacerbacije IPF-a tijekom 52 tjedna bio je značajno smanjen u bolesnika koji su primali nintedanib u usporedbi sa skupinom koja je primala placebo, u ispitivanju INPULSIS-1 nije bilo razlike između skupina liječenja.
In the INPULSIS-2 trial, the risk of first acute IPF exacerbation over 52 weeks was significantly reduced in patients receiving nintedanib compared to placebo, in the INPULSIS-1 trial there was no difference between the treatment groups.

U 24. tjednu, udio bolesnika koji i dalje nije imao plućne egzacerbacije bio je značajno veći u bolesnika liječenih lumakaftorom/ivakaftorom u usporedbi s placebom.
At week 24, the proportion of patients who remained free from pulmonary exacerbations was significantly higher for patients treated with lumacaftor/ivacaftor compared with placebo.

Sadržaj histidina u krvi bolesnika s reumatoidnim artritisom bio je značajno smanjen, a snaga prianjanja, brzina hodanja i sedimentacija eritrocita poboljšani su nakon upotrebe histidina.
The histidine content in blood of patients with rheumatoid arthritis was significantly reduced, and the grip strength, walking and erythrocyte sedimentation rate were improved after using histidine.

U ispitivanju PIPF-004, pad postotka predviđenog FVC-a od početka ispitivanja do 72. tjedna liječenja bio je značajno manji u bolesnika koji su primali Esbriet(N=174) nego u onih koji su primali placebo N=174, p=0, 001, rang ANCOVA.
In study PIPF-004, the decline of percent predicted FVC from Baseline at Week 72 of treatment was significantly reduced in patients receiving Esbriet(N=174) compared with patients receiving placebo N=174; p=0.001, rank ANCOVA.

Udio bolesnika koji su postigli kliničku remisiju prema DAS28(DAS28< 2,6) bio je značajno viši u skupini koja je primala tocilizumab(28-34%) nego u kontrolnoj skupini(1-12%) nakon 24 tjedna.
The proportion of patients achieving a DAS28 clinical remission(DAS28< 2.6) was significantly higher in patients receiving tocilizumab(28-34%) compared to 1-12% of control patients at 24 weeks.

U svim ključnim ispitivanjima avanafila, postotak uspješnih pokušaja spolnih odnosa bio je značajno viši za sve doze avanafila u usporedbi s placebom, za pokušaje u svim ispitivanim vremenskim intervalima poslije uzimanja doze.
Across all of the pivotal trials of avanafil, the percentage of successful intercourse attempts was significantly higher for all doses of avanafil compared to placebo for attempts at all post-dosing time intervals examined.

Afinitet antitijela za domenu HA1 unutar H5 HA u ispitanika primarno cijepljenih P/LAIV H5N1 cjepivom bio je značajno veći nego u skupini ispitanika cijepljenih s dvije doze inaktiviranog cjepiva, što je bilo u korelaciji s križnom neutralizacijom s obzirom na podlinije H5N1.
The affinity of antibodies against the HA1 domain of the H5 HA in the H5N1 P/LAIV-primed groups was significantly higher than the 2- dose inactivated vaccine group, which correlated with cross-clade H5N1 neutralization.

Cialis je bio značajno djelotvorniji od placeba u svim ispitivanjima erektilne disfunkcije.
Cialis was significantly more effective than placebo in all studies in erectile dysfunction.

U ispitivanju MN302 leflunomid je bio značajno manje učinkovit od metotreksata.
In study MN302 leflunomide was significantly less effective than methotrexate.

Su bila značajno veća. Ali odstupanja, koja smo promatrali kod VW vozila.
From the VW passenger cars were significantly higher. But the kind of deviations we were observing.